Literature DB >> 8574817

Glucocorticoid-induced cataract of developing chick embryo as a screening model for anticataract agents.

J W Lee1, M Iwatsuru, H Nishigori.   

Abstract

In order to develop an effective screening model for anticataract agents, we examined the age dependence of cataract induction by glucocorticoid in developing chick embryos. Hydrocortisone sodium succinate (0.25 mumol) was administered to chick embryos on day 15 (15-day-old) and cataract formation was examined 48 hr later. Administration earlier than on day 13 or later than on day 15 was a little or ineffective. These results indicate that the formation of glucocorticoid-induced cataract in developing chick embryos depends on developing stages. The embryos treated with hydrocortisone sodium succinate on day 15 decreased GSH amount in the lens, approximately 50% of the control in 48hr. However, the embryos treated at other ages, in which cataract was not induced, showed little or no decrease of GSH. The cataract formation in chick embryos appeared to depend on structure of steroid and was due to biological activities of glucocorticoids. Since cataract is easily produced in a reproducible manner with high incidence by glucocorticoid, our chick embryo model will be a valuable model system for screening anticataract agents.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8574817     DOI: 10.1089/jop.1995.11.533

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  2 in total

1.  Vehicle of triamcinolone acetonide is associated with retinal toxicity and transient increase of lens density.

Authors:  Wang Kai; Jiang Yanrong; Li Xiaoxin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-02-02       Impact factor: 3.117

2.  Anticataractogenic effect of betaine in chick embryo hydrocortisone-induced cataract model.

Authors:  Reşat Duman; Tolga Ertekin; Rahmi Duman; Ayhan Vurmaz; Ersan Çetinkaya; Hilal Güzel
Journal:  Indian J Med Res       Date:  2019-10       Impact factor: 2.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.